NSAIDs Drug Market Report

Europe NSAIDs Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 13, 2020
  • PAGES：148
  • REPORT CODE：GMM506105
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The NSAIDs Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe NSAIDs Drug Market Segmentations:

    By Player:

    • GSK

    • J&J

    • Merck

    • Depomed

    • Yunnan Baiyao

    • Sanofi

    • Grunenthal

    • Bayer

    • Purdue

    • Eli Lilly

    • Pfizer

    • Endo

    • Allergan

    • AstraZeneca

    • Teva

    By Type:

    • Generic

    • Branded

    By End-User:

    • Hospitals

    • Clinics

    • Drugstores

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of NSAIDs Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe NSAIDs Drug Market Size and Growth Rate of Generic from 2014 to 2026

    • 1.3.2 Europe NSAIDs Drug Market Size and Growth Rate of Branded from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe NSAIDs Drug Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Europe NSAIDs Drug Market Size and Growth Rate of Clinics from 2014 to 2026

    • 1.4.3 Europe NSAIDs Drug Market Size and Growth Rate of Drugstores from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of NSAIDs Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of NSAIDs Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Generic

      • 3.4.2 Market Size and Growth Rate of Branded

    4 Segmentation of NSAIDs Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of NSAIDs Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of NSAIDs Drug for Hospitals

      • 4.4.2 Market Size and Growth Rate of NSAIDs Drug for Clinics

      • 4.4.3 Market Size and Growth Rate of NSAIDs Drug for Drugstores

    5 Market Analysis by Major Regions

    • 5.1 Europe NSAIDs Drug Production Analysis by Top Regions

    • 5.2 Europe NSAIDs Drug Consumption Analysis by Top Regions

    • 5.3 Europe NSAIDs Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of NSAIDs Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in NSAIDs Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in NSAIDs Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in NSAIDs Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in NSAIDs Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in NSAIDs Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in NSAIDs Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany NSAIDs Drug Landscape Analysis

    • 7.1 Germany NSAIDs Drug Landscape Analysis by Major Types

    • 7.2 Germany NSAIDs Drug Landscape Analysis by Major End-Users

    8. UK NSAIDs Drug Landscape Analysis

    • 8.1 UK NSAIDs Drug Landscape Analysis by Major Types

    • 8.2 UK NSAIDs Drug Landscape Analysis by Major End-Users

    9. France NSAIDs Drug Landscape Analysis

    • 9.1 France NSAIDs Drug Landscape Analysis by Major Types

    • 9.2 France NSAIDs Drug Landscape Analysis by Major End-Users

    10. Italy NSAIDs Drug Landscape Analysis

    • 10.1 Italy NSAIDs Drug Landscape Analysis by Major Types

    • 10.2 Italy NSAIDs Drug Landscape Analysis by Major End-Users

    11. Spain NSAIDs Drug Landscape Analysis

    • 11.1 Spain NSAIDs Drug Landscape Analysis by Major Types

    • 11.2 Spain NSAIDs Drug Landscape Analysis by Major End-Users

    12. Poland NSAIDs Drug Landscape Analysis

    • 12.1 Poland NSAIDs Drug Landscape Analysis by Major Types

    • 12.2 Poland NSAIDs Drug Landscape Analysis by Major End-Users

    13. Russia NSAIDs Drug Landscape Analysis

    • 13.1 Russia NSAIDs Drug Landscape Analysis by Major Types

    • 13.2 Russia NSAIDs Drug Landscape Analysis by Major End-Users

    14. Switzerland NSAIDs Drug Landscape Analysis

    • 14.1 Switzerland NSAIDs Drug Landscape Analysis by Major Types

    • 14.2 Switzerland NSAIDs Drug Landscape Analysis by Major End-Users

    15. Turkey NSAIDs Drug Landscape Analysis

    • 15.1 Turkey NSAIDs Drug Landscape Analysis by Major Types

    • 15.2 Turkey NSAIDs Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark NSAIDs Drug Market Volume and Growth Rate

      • 16.3.2 Finland NSAIDs Drug Market Volume and Growth Rate

      • 16.3.3 Norway NSAIDs Drug Market Volume and Growth Rate

      • 16.3.4 Sweden NSAIDs Drug Market Volume and Growth Rate

      • 16.3.6 Iceland NSAIDs Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium NSAIDs Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands NSAIDs Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg NSAIDs Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia NSAIDs Drug Market Volume and Growth Rate

      • 18.3.2 Latvia NSAIDs Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania NSAIDs Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GSK

      • 19.1.1 GSK Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 J&J

      • 19.2.1 J&J Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Merck

      • 19.3.1 Merck Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Depomed

      • 19.4.1 Depomed Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Yunnan Baiyao

      • 19.5.1 Yunnan Baiyao Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Sanofi

      • 19.6.1 Sanofi Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Grunenthal

      • 19.7.1 Grunenthal Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Bayer

      • 19.8.1 Bayer Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Purdue

      • 19.9.1 Purdue Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Eli Lilly

      • 19.10.1 Eli Lilly Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Pfizer

      • 19.11.1 Pfizer Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Endo

      • 19.12.1 Endo Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Allergan

      • 19.13.1 Allergan Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 AstraZeneca

      • 19.14.1 AstraZeneca Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Teva

      • 19.15.1 Teva Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 99 Figures and 117 Tables)

    • Figure Product Picture

    • Figure Europe NSAIDs Drug Market Size and Growth Rate of Generic from 2014 to 2026

    • Figure Europe NSAIDs Drug Market Size and Growth Rate of Branded from 2014 to 2026

    • Figure Europe NSAIDs Drug Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe NSAIDs Drug Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Europe NSAIDs Drug Market Size and Growth Rate of Drugstores from 2014 to 2026

    • Figure Germany NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania NSAIDs Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of NSAIDs Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of NSAIDs Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of NSAIDs Drug by Different Types from 2014 to 2026

    • Table Consumption Share of NSAIDs Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Generic

    • Figure Market Size and Growth Rate of Branded

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of NSAIDs Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of NSAIDs Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Drugstores

    • Table Europe NSAIDs Drug Production by Major Regions

    • Table Europe NSAIDs Drug Production Share by Major Regions

    • Figure Europe NSAIDs Drug Production Share by Major Countries and Regions in 2014

    • Table Europe NSAIDs Drug Consumption by Major Regions

    • Table Europe NSAIDs Drug Consumption Share by Major Regions

    • Table Germany NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table UK NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table France NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Italy NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Spain NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Poland NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Russia NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Turkey NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in NSAIDs Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in NSAIDs Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in NSAIDs Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in NSAIDs Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Germany NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Germany NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Germany NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table UK NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table UK NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table UK NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table France NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table France NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table France NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table France NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Italy NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Italy NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Italy NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Spain NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Spain NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Spain NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Poland NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Poland NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Poland NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Russia NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Russia NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Russia NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Switzerland NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Turkey NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NSAIDs Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NSAIDs Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NSAIDs Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries NSAIDs Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of J&J

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of J&J

    • Figure Sales and Growth Rate Analysis of J&J

    • Figure Revenue and Market Share Analysis of J&J

    • Table Product and Service Introduction of J&J

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Depomed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Depomed

    • Figure Sales and Growth Rate Analysis of Depomed

    • Figure Revenue and Market Share Analysis of Depomed

    • Table Product and Service Introduction of Depomed

    • Table Company Profile and Development Status of Yunnan Baiyao

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yunnan Baiyao

    • Figure Sales and Growth Rate Analysis of Yunnan Baiyao

    • Figure Revenue and Market Share Analysis of Yunnan Baiyao

    • Table Product and Service Introduction of Yunnan Baiyao

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Grunenthal

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grunenthal

    • Figure Sales and Growth Rate Analysis of Grunenthal

    • Figure Revenue and Market Share Analysis of Grunenthal

    • Table Product and Service Introduction of Grunenthal

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Purdue

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue

    • Figure Sales and Growth Rate Analysis of Purdue

    • Figure Revenue and Market Share Analysis of Purdue

    • Table Product and Service Introduction of Purdue

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Endo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo

    • Figure Sales and Growth Rate Analysis of Endo

    • Figure Revenue and Market Share Analysis of Endo

    • Table Product and Service Introduction of Endo

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US